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Case report
A 44-year-old man presented to an emerg-
ency room, complaining of acute breath-
lessness that had started that day. Further 
questioning revealed a 3-day history of diar-
rhoea and a 7-month history of a produc-
tive cough with bloodstained sputum. The 
patient reported having had fevers and night 
sweats for an uncertain period of time. He 
was a known hypertensive, for which he was 
on treatment. He had never been tested for 
HIV and had no known allergies. In terms 
of social habits, he reported being a casual 
smoker for the past 20 years. The only pre-
vious surgical exposure was an explorative 
laparotomy for a stabbed abdomen.
The general examination revealed an 
acutely ill patient. His fingers were clubbed; 
he was not pale but perspiration was noted 
on the face and chest. The vital signs on 
presentation were a heart rate of a 160 bpm, 
a blood pressure of 88/41 mmHg and a 
respiratory rate of 40 breaths per minute. 
Pulse oximetry readings showed a saturation 
of 88% on room air. The cardiovascular 
system examination revealed a rapid, weak 
pulse that appeared regular. There was no 
parasternal heave and the apex was not 
displaced. The jugular venous pressure was 
elevated. Auscultation revealed a gallop 
rhythm, but no murmur could be identified. 
The respiratory system examination showed 
diffuse crepitation on the left and amphoric 
breathing over the right lower lobe.
The differential diagnosis was given as 
pneumonia, pulmonary embolus or ruptured 
pulmonary abscess with a pneumothorax. 
The possibility of an acute myocardial 
infarc tion was also considered.
A chest radiograph (Fig. 1) revealed right 
lower lobe consolidation and an electro-
cardiogram (ECG) showed an atrial flutter. 
No ECG changes suggestive of ischaemia, 
such as ST-segment abnormalities or T-wave 
inversions, were present. A 6 mg dose of 
adeno sine was administered with no effect, 
followed by a 12 mg bolus, which led to a 
5-second asystole. The asystole converted to 
sinus rhythm, which became a supraventri-
cular tachycardia of 140 bpm. The blood 
pressure remained low at 78/60 mmHg. 
The biochemical work-up did not reveal any 
abnormalities except low magnesium levels 
and raised inflammatory markers.
The patient was intubated and admitted to 
the intensive care unit (ICU). Despite admini-
stration of a dobutamine and phenyl ephrine 
infusion, the blood pressure remained low at 
80/60 mmHg and perfusion was inadequate, 
the lactate level increasing from 2.2 to 
3.3  mmol/L.
An amiodarone infusion was started, as 
it was reasoned that the fast heart rate was 
contributing to the poor perfusion. The 
blood pressure improved marginally, but 
the patient started sweating profusely as the 
pulse slowed.
Empirical antibiotic cover with ceftriaxone 
was started in response to raised C-reactive 
protein (CRP) markers (52 mg/L) and the 
clinical and radiological evidence of pneu-
monia.
An echocardiogram revealed massive 
mitral regurgitation and a left ventricular 
ejection fraction of 32%. Decreased move-
ment of the posterior wall of the left ven-
tricle and the interventricular septum was 
noted. The left atrium was dilated, with a 
left atrial aortic outflow tract ratio of 2.1:1. 
The left ventricle was normal in size, while 
the right atrium and ventricle were also 
dilated. Right ventricular and right atrial 
dilatation were present with a normal-sized 
left ventricle. The vena cava collapsibility 
index was <5%.
Furosemide at a dose of 1 mg/h was 
started, to reduce the preload. The serum 
lactate level had increased to 4.4 mmol/L and 
urine output had dropped below 0.5 mL/kg. 
The pulse pressures remained low and the 
patient continued sweating. In consultation 
with the cardiothoracic specialist, it was 
decided to place an intra-aortic balloon 
pump (IABP). The decision was based on 
the poor tissue perfusion despite optimal 
inotropes (dobutamine). The IABP was 
placed on day 1 of ICU care.
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A 44-year-old man presented with cardiogenic shock secondary to acute functional mitral incompetence as well as septic shock related to 
pneumonia. The patient deteriorated haemodynamically despite adequate medical therapy. An echocardiogram revealed a massive mitral 
incompetence and an ejection fraction of 32%. An intra-aortic balloon pump was placed and the patient improved dramatically. On day 6 
after admission the echocardiogram was repeated, revealing a mild mitral incompetence and an ejection fraction of 58%.
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Fig. 1. Chest radiograph showing right lower lobe 
consolidation (arrow).
IN PRACTICE
790       August 2016, Vol. 106, No. 8
The IABP was started on a 1:1 ratio and the 
haemodynamics improved immediately. The 
blood pressure improved to 105/70  mmHg 
and the pulse rate varied between 100  and 
115 bpm. The lactate levels started to 
decrease, urine output increased and the 
patient stopped sweating. The dobutamine 
was weaned to a quarter of the pre-IABP 
dose within 24 hours and the phenylephrine 
stopped. On the morning of day 3, the anti-
biotic treatment was upscaled to include 
imipenem, as the inflammatory markers had 
deteriorated (procalcitonin 100  ng/mL and 
CRP 336 mg/L). The dose of furosemide was 
decreased to 0.5 mg/h.
Power, generator and equipment fail ures 
meant that the IABP had to be urgent-
ly removed on the evening of day 3. 
Fortunately, the patient could be maintained 
on low-dose dobutamine. He was extubated 
the next day (day 4), and his haemodynamic 
measurements and perfusion parameters 
were normal. He was kept in the ICU until 
the following day, when he was discharged 
to the ward. An echocardiogram was repeat-
ed 5 days after the initial one, which was 
1 day after discharge from the ICU, and 
revealed minimal mitral regurgitation and 
improvement in the ejection fraction to 
58%, with normal septal and posterior wall 
movement.
From a cardiovascular perspective, the 
patient was stable and out of danger. Further-
more, it was established that he was HIV-
positive with a CD4 count of 129 cells/µL. The 
work-up for pneumonia was disappointing, 
with negative results from cultures, for acid-
fast bacilli and from GeneXpert. Initial blood 
cultures contained a Clostridium species, but 
follow-up blood cultures had no growth 
after a week. The septic markers (Table 1) 
dropped dramatically with the change of 
antibiotics to imipenem.
Discussion
Acute severe mitral incompetence
Acute mitral incompetence in patients with 
cardiogenic shock has an observed mortality 
of 55%, which is marginally improved to 
39% in patients selected for emergency 
surgery. Severe mitral incompetence affects 
about 7% of patients with cardiogenic 
shock.[1,2]
Acute mitral incompetence can be classi-
fied as organic or functional. Organic causes 
result in physical disruption of the valve, 
while functional incompetence results from 
abnormalities of the left ventricle. The causes 
of acute mitral incompetence are listed in 
Table 2.
Differentiation between the two groups is 
very important, as organic causes are usually 
treated surgically and functional causes can 
be managed supportively, with medication 
and the use of an IABP while the underlying 
cause is addressed.[1]
Pathophysiology of acute mitral 
incompetence
Acute mitral incompetence differs from 
chronic incompetence in that there is no 
time for remodelling.[1,3] The stroke volume 
is decreased, which can be due to ventricular 
dysfunction as well as retrograde flow from 
the left ventricle into the left atrium.[1-3] The 
decreased stroke volume is compensated 
for by tachycardia in an effort to maintain 
cardiac output. When compensation fails, 
the patient will present with hypotension and 
end-organ failure presenting as cardiogenic 
shock.[1,2]
The regurgitation into the left atrium 
results in raised left atrial pressures and 
pul monary wedge pressures that lead to 
pulmonary oedema.[1-3] Numerous cases have 
been reported presenting with unilateral 
pulmonary oedema, usually on the right 
side and confined to the upper lobe.[3,4] 
This is often confused with pneumonia. [4] 
Symptoms are related to the fraction of 
the stroke volume that is regurgitated. 
Regurgitation of <30% of the stroke volume 
usually presents with mild symptoms, 30 - 
60% regurgitation with moderate symptoms, 
and regurgitation of >60% with severe 
symptoms.
Differentiating between acute and 
chronic mitral incompetence
A combination of pulmonary cardiac cathe-
ter measurements and ultrasonography is 
used to differentiate between acute and 
chronic mitral regurgitation. The difference 
in findings is based on the time for 
compensation. Table 3 summarises the basic 
differences.[1]
Clinical presentation
The usual triad of dyspnoea, haemodynamic 
instability and shock is not always present in 
patients with acute mitral incompetence. [1] 
Auscultation can be misleading, as the new 
murmur may be subtle and masked by the 
compensatory tachycardia.[1] However, the 
Table 1. Blood results
10/2/15 11/2/15 12/2/15 13/2/15 14/2/15 15/2/15 17/2/15
White cell count 
(×109/L)
5.5 11.9 9.9 10.7 10.7 9.6 7.6
CRP (mg/L) 52 227 336 200 120 77 26
Procalcitonin 
(ng/mL)
- 100 100 77 43 19 3
Table 2. Causes of acute mitral incompetence[1,2]
Organic causes of acute mitral 
incompetence
Functional causes of acute mitral 
incompetence
Leaflet perforation or chordae tendineae 
rupture from endocarditis
Dilated cardiomyopathy leads to leaflet 
tethering
Chordal rupture in myxomatous valvular 
disease
Acute ischaemic akinesis of wall segments and 
papillary muscle dysfunction
Papillary muscle rupture due to myocardial 
infarction
Takotsubo’s cardiomyopathy
Prosthetic valve dysfunction due to endocarditis





Cardiac output Normal Decreased
Ejection fraction Increased Normal or decreased
Left ventricular size Increased Normal
Left atrial compliance Normal Normal
Left ventricular end-diastolic pressure Normal Markedly increased
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murmur, when identified, is pansystolic and best heard at the apex of 
the heart with the patient in the lateral decubitus position.[2] When the 
afterload is increased, for example by strong hand grip or squatting, 
the murmur is accentuated. Using similar logic, the intensity of the 
murmur is decreased by standing and the valsalva manoeuvre.[2] 
Tachypnoea and associated pulmonary oedema can further increase 
the difficulty of auscultation. Any signs that could suggest myocardial 
infarction should prompt thorough investigation, as this remains 
the most common cause of acute mitral regurgitation. [1] Patients 
presenting with fever in association with the above signs should be 
worked up for infective endocarditis.
As the clinical signs of acute valvular pathology are not always 
obvious, a high index of suspicion should be maintained. If acute 
valvular pathology is suspected, the patient should receive an ECG, 
chest radiograph and echocardiography.[1,2] The echocardiographic 
findings that determine the severity of mitral regurgitation are 
summarised in Table 4.
Transoesophageal echocardiography (TEE) provides a more 
detailed view and should be used if endocarditis or valvular thrombi 
are suspected.[2] The use of TEE has become increasingly important 
in the assessment of mitral incompetence as it is highly specific and 
sensitive for numerous causes and helps to localise the problem 
area with more precision. It is essential in the planning of surgical 
intervention.[1,2] In patients with pulmonary artery catheters in situ, 
moderate and severe mitral incompetence can be recognised by a 
large v wave and a rapid y descent.[2]
The routine blood tests should include a full blood count, 
electrolyte profile and urea, and creatinine should be tested together 
with troponin and B-type natriuretic peptide (BNP) levels.[1,5]
Management of acute mitral incompetence 
The general management of acute mitral incompetence includes 
reducing afterload and maintaining a fast-normal heart rate (80  - 
100  bpm). Care should be taken to prevent sudden increases in 
afterload, for example, during intubation and surgical stimulus, as 
this will increase the regurgitation fraction.
In the management of acute mitral incompetence with an organic 
cause, supportive therapy can stabilise patients long enough to 
prepare the operating suite. Medical therapy is not a substitute for 
surgical intervention in these patients. Valve repair or replacement is 
the definitive treatment, while the use of dobutamine, nitroprusside 
and nitroglycerine are temporary measures. The use of an IABP 
may be beneficial in these patients. Surgical treatment is reserved 
for patients with a regurgitant fraction >30%. Whenever possible, 
valve repair is preferred to replacement as the prognosis is better and 
anticoagulants are not needed.[1,3]
In the management of acute mitral incompetence with functional 
causes, supportive therapy may be sufficient and surgical intervention 
not required unless initial supportive measures fail. The aim is to 
optimise the perfusion of the heart and thus the affected area. The use 
of an IABP is effective in all cases of functional mitral incompetence, 
and this is especially true for cases of myocardial ischaemia or 
cardiomyopathy.[1,3]
Prognosis
There are limited studies on the prognosis of patients with acute 
mitral incompetence. Numerous studies have been done on increased 
mortality from ischaemic mitral incompetence following myocardial 
infarction and the presence of mitral incompetence post-infarction 
is a poor prognostic sign.[6] Studies on the prognosis of acute 
functional mitral incompetence are few and none have ventured to 
assign values to mortality. Studies have shown that the degree of left 
ventricular dysfunction is not proportionate to the severity of the 
mitral incompetence and it is therefore impossible to draw accurate 
correlations between severity and outcome.[7] Functional mitral 
regurgitation is a poor prognostic sign in left ventricular dysfunction 
caused by cardiomyopathy or ischaemic disease.[7]
BNP measurement is being used increasingly as a prognostic tool. 
Its use in relation to functional mitral incompetence has not been 
specifically studied. A correlation between a raised BNP level and an 
increased number of adverse events under conservative management 
has been observed. BNP measurement should be used in conjunction 
with other risk stratification tools and clinical evaluation.[5]
Aggressive early surgical management of patients with acute 
organic mitral incompetence has been shown to decrease mortality.[1]
Conclusion
The incidence of acute functional mitral incompetence is dwarfed 
by the incidence of acute organic mitral incompetence. However, it 
is important to exclude acute functional mitral incompetence, which 
has markedly different management to and much lower morbidity 
and mortality than acute organic mitral incompetence.
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Table 4. Echocardiographic findings in acute mitral regurgitation[2]
Mild Moderate Severe
Regurgitant volume (mL/beat) <30 30 - 59 ≥60
Regurgitant fraction (%) <30 30 - 49 ≥50
Effective regurgitant orifice area (cm2) <0.20 0.20 - 0.39 ≥0.40
Vena contracta width (cm) <0.30 ≥0.70
